Why the study?
The efficacy and safety of corticosteroid-containing protocols during cardiopulmonary resuscitation for adult in-hospital cardiac arrest remained uncertain.
Comparison
Corticosteroid-containing resuscitation protocols (n = 713) vs control protocols (n = 776)
Design
Systematic review and random-effects meta-analysis of randomized controlled trials
Follow-up
To hospital discharge and 30 days
Answers are grounded in this paper and cite their sources.
Corticosteroid-containing protocols raise ROSC odds in cardiac arrest; extends meta-analytic support for adjunctive resuscitation therapies.
Background: The role of corticosteroids during cardiopulmonary resuscitation for adult in-hospital cardiac arrest (IHCA) remains uncertain. This systematic review and meta-analysis evaluated the efficacy and safety of corticosteroid-containing resuscitation protocols in adults with IHCA. Methods: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to evaluate corticosteroid-containing resuscitation protocols in adults with IHCA. PubMed, Embase, CINAHL, Web of Science Core Collection, and ClinicalTrials.gov were searched from database inception to July 2026, with restriction to publications in English. The primary outcomes were return of spontaneous circulation (ROSC), survival to hospital discharge, and favorable neurological outcome. Secondary outcomes included 30-day or available survival duration, corticosteroid-related adverse events, and length of hospital stay. Random-effects meta-analyses were performed where clinically appropriate, with subgroup analyses according to concomitant vasopressin administration and follow-up time. Results: Seven RCTs involving 1489 participants were included. A total of 713 participants were assigned to corticosteroid-containing resuscitation protocols and 776 to control protocols. Corticosteroid-containing resuscitation protocols were associated with higher odds of ROSC than control protocols (OR, 1.87; 95% CI, 1.22–2.86, p = 0.004; moderate-certainty evidence). Statistically significant benefit was demonstrated for survival to hospital discharge (OR, 2.92; 95% CI, 1.44–5.95; p = 0.003) but no statistically significant benefit for favorable neurological outcome (OR, 1.20; 95% CI, 0.62–2.32, p = 0.58), with low-certainty evidence for both outcomes. Follow-up-specific survival estimates were heterogeneous and imprecise. Adverse events and length of hospital stay were inconsistently reported and were not suitable for pooled analysis. Conclusions: Corticosteroid-containing resuscitation protocols may improve ROSC in adults with IHCA; however, evidence is insufficient to establish whether this translates into improved survival or neurological recovery. Because the evaluated interventions included varying combinations of corticosteroids, vasopressin, epinephrine, and post-resuscitation hydrocortisone, the observed effects cannot be attributed to corticosteroids alone. Larger, adequately powered multicenter RCTs using standardized protocols and patient-centered long-term outcomes are needed.
No takes yet. Share an insight, caveat, or question.
Al-Sadah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: